Developing Story: DOJ Will Dismiss Qui Tam Cases Lacking Merit

New policy changes from DOJ will impact False Claims Act cases moving forward.

In announcing a significant policy change, the U.S. Department of Justice (DOJ) said that when it concludes that a qui tam case lacks merit, it will file a motion to dismiss the case rather than allowing the relator to continue.

The surprise announcement was made by Michael Granston, director of the commercial litigation branch of the fraud section in the DOJ’s civil division, during the Health Care Compliance Association’s Health Care Enforcement Compliance Institute in Washington, D.C. on Monday.

Under the False Claims Act, when a relator or whistleblower files a qui tam action, the government has 60 days to determine whether it either takes over the litigation or declines to intervene in the case. Under the latter circumstances, the relator must determine whether to proceed using the relator’s own resources. (Note that courts nearly always extend that 60-day limit.)

While the federal government has always had the authority to dismiss a False Claims Act case, it has rarely done so. I am aware of two such cases, one in California and the other, in which I was involved, in Minnesota. Shortly after we celebrated the dismissal of the case, we learned that the DOJ had changed its position and would allow all cases to proceed if the relator was willing to do the work, even if the DOJ didn’t find the case meritorious.

During his presentation on Monday, Granston explained that the government recognizes that frivolous litigation creates a burden, not only for the government, but also for the courts and the healthcare industry. Therefore, when the DOJ concludes that a case is baseless going forward, it will file a motion to dismiss it.

The DOJ’s decision to file for a dismissal doesn’t guarantee the result; in theory, a judge could refuse to grant the motion and allow the case to proceed. However, from a practical perspective, such a result is unlikely. While it is impossible to predict how often the DOJ will seek dismissal of a case, the fact that the option exists is welcome news to the healthcare industry. Granston also provided some insight on the DOJ’s priorities over the next year. The government will be examining a variety of issues related to electronic health record (EHR) software, including whether the software documents information correctly and whether it properly qualifies for various incentive payments.

Diagnosis coding under Medicare Part C, often called the Medicare Advantage program, is also receiving scrutiny. Granston noted that the Part C program currently constitutes approximately one-third of all Medicare beneficiaries and accounts for approximately one-quarter of all Medicare spending. The government is concerned that some plans are reporting diagnoses that are not properly supported by the record, resulting in overpayments to the plan.

The government is also very interested in pursuing cases involving the delivery of substandard care, particularly in the skilled nursing facility (SNF) setting.

Finally, according to Granston, the government will be devoting considerable resources to resolving two open questions in the courts. In the Aseracare Hospice case, the judge concluded that if there is a dispute about medical necessity and an expert testifies that the care is necessary, the government cannot prevail in a False Claims Act case. The DOJ is deeply troubled by that result and hopes to reverse it on appeal. In addition, the courts have not yet definitively determined whether statistical sampling is allowed in a False Claims Act case. The government is hoping to convince the courts that sampling is appropriate.

Facebook
Twitter
LinkedIn
Email
Print

David M. Glaser, Esq.

David M. Glaser is a shareholder in Fredrikson & Byron's Health Law Group. David assists clinics, hospitals, and other health care entities negotiate the maze of healthcare regulations, providing advice about risk management, reimbursement, and business planning issues. He has considerable experience in healthcare regulation and litigation, including compliance, criminal and civil fraud investigations, and reimbursement disputes. David's goal is to explain the government's enforcement position, and to analyze whether this position is supported by the law or represents government overreaching. David is a member of the RACmonitor editorial board and is a popular guest on Monitor Mondays.

Related Stories

The Perils of E&M Codes and Insurance

The Perils of E&M Codes and Insurance

Lately, I have been inundated with Medicare and Medicaid healthcare providers getting audited for evaluation and management (E&M) codes. I know Dr. Hirsch (Ronald Hirsch,

Read More
What Happens When AI is Wrong?

What Happens When AI is Wrong?

I recently asked a question to ChatGPT, the artificial intelligence (AI) chatbot launched late last year. I got a well-worded response that made a lot

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

Mastering Good Faith Estimates Under the No Surprises Act: Compliance and Best Practices

Mastering Good Faith Estimates Under the No Surprises Act: Compliance and Best Practices

The No Surprises Act (NSA) presents a challenge for hospitals and providers who must provide Good Faith Estimates (GFEs) for all schedulable services for self-pay and uninsured patients. Compliance is necessary, but few hospitals have been able to fully comply with the requirements despite being a year into the NSA. This webcast provides an overview of the NSA/GFE policy, its impact, and a step-by-step process to adhere to the requirements and avoid non-compliance penalties.

Mastering E&M Guidelines: Empowering Providers for Accurate Service Documentation and Scenario Understanding in 2023

Mastering E&M Guidelines: Empowering Providers for Accurate Service Documentation and Scenario Understanding in 2023

This expert-guided webcast will showcase tips for providers to ensure appropriate capture of the work performed for a visit. Comprehensive examples will be given that demonstrate documentation gaps and how to educate providers on the documentation necessary to appropriately assign a level of service. You will gain clarification on answers regarding emergency department and urgent care coding circumstances as well as a review of how/when it is appropriate to code for E&M in radiology and more.

June 21, 2023
Breaking Down the Proposed IPPS Rule for FY 2024: Top Impacts You Need to Know

Breaking Down the Proposed IPPS Rule for FY 2024: Top Impacts You Need to Know

Set yourself up for financial and compliance success with expert guidance that breaks down the impactful changes including MS-DRG methodology, surgical hierarchy updates, and many new technology add-on payments (NTAPs). Identify areas of potential challenge ahead of time and master solutions for all 2024 Proposed IPPS changes.

May 24, 2023

Trending News